Search filters

List of works by Clive S Zent

A Distributed International Patient Data Registry for Hairy Cell Leukemia

A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited

scientific article published in July 2011

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

scientific article

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

scientific article

A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).

scientific article published on 10 December 2015

Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

scientific article published on 22 August 2012

Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)

scientific article published on 16 March 2020

Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia

scientific article published in September 2004

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

scientific article published on October 2010

Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium

scientific article published on May 2004

Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies

scientific article published on 11 July 2017

Anti-CD20 antibody therapy for B-cell lymphomas

scientific article published on 01 August 2012

Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages

scientific article

Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.

scientific article

Association of an increased frequency of CD14+HLA‐DRlo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)

scientific article published on November 3, 2011

Autoimmune complications in chronic lymphocytic leukaemia (CLL).

scientific article

Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis

scientific article

Autoimmunity and chronic lymphocytic leukemia

scientific article published in August 2006

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

scientific article

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

scientific article published on 08 September 2009

Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance

scientific article (publication date: October 2011)

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia

scientific article published on 20 July 2009

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.

scientific article published on 21 February 2019

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

scientific article published on March 2008

CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma

scientific article published on 01 April 2010

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.

scientific article

CLL: an acquired immunodeficiency disease.

scientific article

CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

scientific article published on June 28, 2013

Cell-mediated immunity in chronic lymphocytic leukemia

scientific article published on 01 October 2010

Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies

scientific article published on 08 August 2018

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL c

scientific article

Chronic B-cell lymphoproliferative disorders: how many diseases?

scientific article published on 01 October 2006

Chronic lymphocytic leukemia and proteomics: protein profiles and links with disease progression still need validation

scientific article published on 4 January 2016

Chronic lymphocytic leukemia: biology and current treatment

scientific article published on September 2007

Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis

scientific article published in October 2009

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

scientific article published in December 2005

Clinical significance of monoclonal B cells in cerebrospinal fluid

scientific article published on 01 January 2005

Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment

scientific article published on 09 March 2020

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

scientific article

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

scientific article published on January 2008

Complement Activation in the Treatment of B-Cell Malignancies

scientific article published on 01 December 2020

Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement

scientific article published on May 21, 2012

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

scientific article

Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications

scientific article published on 01 February 2010

Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/ small lymphocytic lymphoma

scientific article

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression

scientific article published on October 6, 2011

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

scientific article

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

scientific article published on 27 June 2008

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

scientific article

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

scientific article

Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma

scientific article published on 17 December 2019

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia

scientific article

FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes

scientific article published on 03 May 2011

Genetic risk of chronic lymphocytic leukemia: a tale of two cities

scientific article

Germline variation in complement genes and event‐free survival in follicular and diffuse large B‐cell lymphoma

scientific article published on June 20, 2012

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

scientific article published on 04 May 2021

Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

scientific article published on 26 August 2011

Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.

scientific article

High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging

scientific article published on 05 March 2020

Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience

scientific article published on 13 October 2018

Ibrutinib therapy for lymphoplasmacytic lymphoma

scientific article

Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients

scientific article

Improving quality of life in chronic lymphocytic leukemia

scientific article published on February 13, 2012

Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines

scientific article

Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes

scientific article published on 01 August 2006

Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia

scientific article

Infection in chronic lymphocytic leukemia: parsimony has its limits

scientific article published on 16 May 2014

Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication

scientific article published on 25 June 2014

Initial treatment of B-cell prolymphocytic leukemia with ibrutinib

scientific article published on 17 January 2020

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia

scientific article published in July 2005

Intravascular B-cell lymphoma (angiotropic lymphoma) with choroidal involvement

scientific article

Linezolid-induced pure red blood cell aplasia

scientific article

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).

scientific article published on 14 March 2013

Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia

scientific article published on 01 June 2006

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

scientific article published on 07 January 2008

Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance

scientific article published on 17 June 2020

Management of autoimmune cytopenia complicating chronic lymphocytic leukemia

scientific article

Management of chronic lymphocytic leukemia

scientific article published on 01 January 2015

Management of melanoma in patients with chronic lymphocytic leukemia

scientific article published on 06 July 2018

Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach

scientific article

Mantle cell lymphoma presenting as a slowly enlarging lesion of the floor of mouth in a healthy 72-year-old female: Report of a case

scientific article published in February 2007

Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity

scientific article published on 14 November 2016

Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab

scientific article

Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia

scientific article

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

scientific article published in December 2007

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia

scientific article

Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?

scientific article

Multi-parameter prognostication in chronic lymphocytic leukemia

scientific article published on 08 July 2011

Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications

scientific article published on 11 January 2020

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53.

scientific article

Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia

scientific article

Ofatumumab‐based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)

scientific article published on 06 August 2013

Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.

scientific article published on 6 September 2016

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial

scientific article published on 26 September 2018

Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis

scientific article published on 27 August 2013

Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia

scientific article

Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia

scientific article

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

scientific article published on 02 March 2009

Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

scientific article published on 03 July 2012

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

scientific article

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia

scientific article published on 26 May 2009

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia

scientific article published on November 5, 2010

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia

scientific article published on 10 July 2009

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

scientific article published on April 2008

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia

scientific article

Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients

scientific article published in October 2007

Real world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.

scientific article

Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells.

scientific article

Recurrent fevers, cough, and pulmonary opacities in a middle-aged man.

scientific article published on June 2010

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia

scientific article published in November 2007

Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma

scientific article published on 30 October 2020

Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy

scientific article published on 03 November 2019

Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis

scientific article published in December 2006

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

scientific article published on July 2010

Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on May 2008

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population

scientific article published on 12 August 2011

Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 19 March 2013

The ABC of chronic lymphocytic leukemia: etiology of cytopenias is important in staging and management

scientific article published in November 2013

The academic hematology-oncology firm:a model for postgraduate cancer education

scientific article published on 01 January 2004

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype

scientific article published on 01 September 2003

The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia

scientific article published on 25 July 2008

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

scientific article

The role of alemtuzumab in the treatment of chronic lymphocytic leukemia

scientific article

The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation

scientific article

Time to test CLL p53 function

scientific article published on 01 May 2010

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

scientific article published in February 2018

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma

scientific article published on 25 October 2020

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

scientific article

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study

scientific article published on 24 December 2015

Update on monoclonal antibody therapy in chronic lymphocytic leukemia.

scientific article

Update on risk-stratified management for chronic lymphocytic leukemia

scientific article published on September 2006

Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 17 February 2014

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test

scientific article

Validation of a new prognostic index for patients with chronic lymphocytic leukemia

scientific article published on January 2009

Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death

scientific article published in March 2004

Visual loss in early-stage chronic lymphocytic leukemia

scientific article

Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia

scientific article

What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

scientific article

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).

scientific article published in August 2008

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels

scientific article published on 13 September 2018